Editorial Commentary
Harnessing transcriptomics and immune cell biology to predict response to checkpoint blockade
Translational Cancer Research
2024;
13
(10)
:5162-5164
.
(31 October 2024)
Original Article
Risk signature of NETosis‐related subtype predicts prognosis and evaluates immunotherapy effectiveness in gastric cancer
Translational Cancer Research
2024;
13
(10)
:5165-5177
.
(31 October 2024)
Identifying functional cuproptosis-related long non-coding RNAs in patients with bladder cancer
Translational Cancer Research
2024;
13
(10)
:5178-5189
.
(31 October 2024)
Oncogenic role of SKA2 and its ceRNA network in hepatocellular carcinoma based on a comprehensive analysis
Translational Cancer Research
2024;
13
(10)
:5190-5201
.
(31 October 2024)
Study on the expression of lncRNA PRKCA-AS1 in oral squamous cell carcinoma
Translational Cancer Research
2024;
13
(10)
:5202-5213
.
(31 October 2024)
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer
Translational Cancer Research
2024;
13
(10)
:5214-5232
.
(31 October 2024)
Construction and validation of prognostic model for colorectal mucinous adenocarcinoma patients and identification of a new prognosis related gene FAM174B
Translational Cancer Research
2024;
13
(10)
:5233-5246
.
(31 October 2024)
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response
Translational Cancer Research
2024;
13
(10)
:5247-5264
.
(31 October 2024)
S100A1 overexpression stimulates cell proliferation and is predictive of poor outcome in ovarian cancer
Translational Cancer Research
2024;
13
(10)
:5265-5277
.
(31 October 2024)
Exploring SSR1 as a novel diagnostic and prognostic biomarker in hepatocellular carcinoma, and its relationship with immune infiltration
Translational Cancer Research
2024;
13
(10)
:5278-5299
.
(31 October 2024)
HDAC1: a promising target for cancer treatment: insights from a thorough analysis of tumor functions
Translational Cancer Research
2024;
13
(10)
:5300-5315
.
(31 October 2024)
Up-regulation of MSMO1 was associated with poor survival in cervical cancer
Translational Cancer Research
2024;
13
(10)
:5316-5327
.
(31 October 2024)
Optimal preservation condition for the extraction of cell-free DNA from bile of patients with biliary tract cancer
Translational Cancer Research
2024;
13
(10)
:5328-5338
.
(31 October 2024)
Prognostic impact of concordant and discordant bone marrow involvement on diffuse large B-cell lymphoma
Translational Cancer Research
2024;
13
(10)
:5339-5346
.
(31 October 2024)
LncRNA AF117829.1 is correlated with prognosis and immune infiltration and facilitates tumor progression by targeting OR7C1 in colorectal cancer
Translational Cancer Research
2024;
13
(10)
:5347-5364
.
(31 October 2024)
Exosomal AHSG in ovarian cancer ascites inhibits malignant progression of ovarian cancer by p53/FAK/Src signaling
Translational Cancer Research
2024;
13
(10)
:5365-5380
.
(31 October 2024)
Establishment and validation of a prediction model for gastric cancer with perineural invasion based on preoperative inflammatory markers
Translational Cancer Research
2024;
13
(10)
:5381-5394
.
(31 October 2024)
Identification and validation of a novel innate lymphoid cell-based signature to predict prognosis and immune response in liver cancer by integrated single-cell RNA analysis and bulk RNA sequencing
Translational Cancer Research
2024;
13
(10)
:5395-5416
.
(31 October 2024)
Brain metastases in newly diagnosed lung cancer: epidemiology and conditional survival
Translational Cancer Research
2024;
13
(10)
:5417-5428
.
(31 October 2024)
Prognostic value and anti-tumor immunity role of TMED9 in pan-cancer: a bioinformatics study
Translational Cancer Research
2024;
13
(10)
:5429-5445
.
(31 October 2024)
Clinical prognostic value of TREM1 in patients with liver cancer lung metastasis
Translational Cancer Research
2024;
13
(10)
:5446-5457
.
(31 October 2024)
Identification of anoikis-related long non-coding RNA signature as a novel prognostic model in lung adenocarcinoma
Translational Cancer Research
2024;
13
(10)
:5458-5472
.
(31 October 2024)
Pathomics signatures and cuproptosis-related genes signatures for prediction of prognosis in patients with hepatocellular carcinoma
Translational Cancer Research
2024;
13
(10)
:5473-5483
.
(31 October 2024)
ISL1 and AQP5 complement each other to enhance gastric cancer cell stemness by regulating CD44 expression
Translational Cancer Research
2024;
13
(10)
:5484-5496
.
(31 October 2024)
Nomogram for predicting 10-year postoperative recurrence of stage I gastric cancer
Translational Cancer Research
2024;
13
(10)
:5497-5508
.
(31 October 2024)
MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR
Translational Cancer Research
2024;
13
(10)
:5509-5521
.
(31 October 2024)
Bioinformatics analysis reveals SOD1 is a prognostic factor in lung adenocarcinoma
Translational Cancer Research
2024;
13
(10)
:5522-5534
.
(31 October 2024)
The role of SEC14L4 in esophageal squamous cell cancer: insights into clinical relevance and molecular pathways
Translational Cancer Research
2024;
13
(10)
:5535-5549
.
(31 October 2024)
Exploring a specific type of tissue-resident natural killer cell involved in the anti-tumor and immunotherapy response in human papillomavirus-positive head and neck squamous cell carcinoma using scRNA-seq
Translational Cancer Research
2024;
13
(10)
:5550-5562
.
(31 October 2024)
Screening of potential key pathogenic and intervention targets of low-grade glioma based on bioinformatics
Translational Cancer Research
2024;
13
(10)
:5563-5573
.
(31 October 2024)
Sini decoction-polysaccharide compound regulates proliferation, apoptosis, and glycolysis of liver cancer cells through PHLDA2/ANXA2
Translational Cancer Research
2024;
13
(10)
:5574-5587
.
(31 October 2024)
The onset characteristics and prognosis of patients with radiation-associated second primary malignancy: a pancancer study in the US SEER cancer registries
Translational Cancer Research
2024;
13
(10)
:5588-5599
.
(31 October 2024)
Establishment and verification of a prognostic immune cell signature-based model for breast cancer overall survival
Translational Cancer Research
2024;
13
(10)
:5600-5615
.
(31 October 2024)
Exploring the key pathogenic mechanisms and potential intervention targets for Sophorae Flavescentis radix in managing bone metastasis of lung cancer based on network pharmacology and molecular docking techniques
Translational Cancer Research
2024;
13
(10)
:5616-5626
.
(31 October 2024)
PYGL regulation of glycolysis and apoptosis in glioma cells under hypoxic conditions via HIF1α-dependent mechanisms
Translational Cancer Research
2024;
13
(10)
:5627-5648
.
(31 October 2024)
Review Article
The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review
Translational Cancer Research
2024;
13
(10)
:5649-5663
.
(31 October 2024)
Krukenberg tumours: which patients should be considered for surgery?—a narrative literature review
Translational Cancer Research
2024;
13
(10)
:5664-5677
.
(31 October 2024)
Research progress on the correlation between obesity and the occurrence and development of kidney cancer: a narrative review
Translational Cancer Research
2024;
13
(10)
:5678-5690
.
(31 October 2024)
Relationship between adipocytes and hematological tumors in the bone marrow microenvironment: a literature review
Translational Cancer Research
2024;
13
(10)
:5691-5701
.
(31 October 2024)
The potential role of Ral-interacting protein 76 and vascular endothelial growth factor on angiogenesis in the tumor and ovarian corpus luteum microenvironment
Translational Cancer Research
2024;
13
(10)
:5702-5710
.
(31 October 2024)
Case Report
Capicua transcriptional repressor (CIC)-rearranged sarcoma harboring CIC-LEUTX fusion with renal involvement: a rare case report
Translational Cancer Research
2024;
13
(10)
:5711-5718
.
(31 October 2024)
Erratum
Erratum: Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma
Translational Cancer Research
2024;
13
(10)
:5719-5720
.
(31 October 2024)
Retraction
Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling
Translational Cancer Research
2024;
13
(10)
:5721-5722
.
(31 October 2024)
